Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 135

1.

Plasma exchange versus intravenous immunoglobulin for myasthenia gravis crisis: an acute hospital cost comparison study.

Heatwole C, Johnson N, Holloway R, Noyes K.

J Clin Neuromuscul Dis. 2011 Dec;13(2):85-94. doi: 10.1097/CND.0b013e31822c34dd.

2.

Cost-minimization analysis comparing intravenous immunoglobulin with plasma exchange in the management of patients with myasthenia gravis.

Furlan JC, Barth D, Barnett C, Bril V.

Muscle Nerve. 2016 Jun;53(6):872-6. doi: 10.1002/mus.24960. Epub 2015 Nov 26.

PMID:
26521889
3.

Intravenous immunoglobulin for myasthenia gravis.

Gajdos P, Chevret S, Toyka K.

Cochrane Database Syst Rev. 2008 Jan 23;(1):CD002277. doi: 10.1002/14651858.CD002277.pub3. Review. Update in: Cochrane Database Syst Rev. 2012;12:CD002277.

PMID:
18254004
4.

Intravenous immunoglobulin for myasthenia gravis.

Gajdos P, Chevret S, Toyka KV.

Cochrane Database Syst Rev. 2012 Dec 12;12:CD002277. doi: 10.1002/14651858.CD002277.pub4. Review.

PMID:
23235588
5.

IVIG Versus PLEX in the Treatment of Worsening Myasthenia Gravis: What is the Evidence?: A Critically Appraised Topic.

Dhawan PS, Goodman BP, Harper CM, Bosch PE, Hoffman-Snyder CR, Wellik KE, Wingerchuk DM, Demaerschalk BM.

Neurologist. 2015 May;19(5):145-8. doi: 10.1097/NRL.0000000000000026.

PMID:
25970838
6.

A comparison between IVIG and plasma exchange as preparations before thymectomy in myasthenia gravis patients.

Alipour-Faz A, Shojaei M, Peyvandi H, Ramzi D, Oroei M, Ghadiri F, Peyvandi M.

Acta Neurol Belg. 2017 Mar;117(1):245-249. doi: 10.1007/s13760-016-0689-z. Epub 2016 Aug 16.

PMID:
27530310
7.

Intravenous immunoglobulin for myasthenia gravis.

Gajdos P, Chevret S, Toyka K.

Cochrane Database Syst Rev. 2006 Apr 19;(2):CD002277. Review. Update in: Cochrane Database Syst Rev. 2008;(1):CD002277.

PMID:
16625559
8.

Plasmapheresis or intravenous immunoglobulin for myasthenia gravis crisis in King Chulalongkorn Memorial Hospital.

Pittayanon R, Treeprasertsuk S, Phanthumchinda K.

J Med Assoc Thai. 2009 Apr;92(4):478-82.

PMID:
19374297
9.

Intravenous immunoglobulin for myasthenia gravis.

Gajdos P, Chevret S, Toyka K.

Cochrane Database Syst Rev. 2003;(2):CD002277. Review. Update in: Cochrane Database Syst Rev. 2006;(2):CD002277.

PMID:
12804431
10.

Comparative analysis of therapeutic options used for myasthenia gravis.

Mandawat A, Kaminski HJ, Cutter G, Katirji B, Alshekhlee A.

Ann Neurol. 2010 Dec;68(6):797-805. doi: 10.1002/ana.22139.

PMID:
21061395
11.

IVIG and PLEX in the treatment of myasthenia gravis.

Bril V, Barnett-Tapia C, Barth D, Katzberg HD.

Ann N Y Acad Sci. 2012 Dec;1275:1-6. doi: 10.1111/j.1749-6632.2012.06767.x.

PMID:
23278570
12.

Estimated cost of treating myasthenia gravis in an insured U.S. population.

Guptill JT, Sharma BK, Marano A, Soucy A, Krueger A, Sanders DB.

Muscle Nerve. 2012 Mar;45(3):363-6. doi: 10.1002/mus.22327.

PMID:
22334170
13.

A comparison of the effectiveness of intravenous immunoglobulin and plasma exchange as preoperative therapy of myasthenia gravis.

Jensen P, Bril V.

J Clin Neuromuscul Dis. 2008 Mar;9(3):352-5. doi: 10.1097/CND.0b013e3181660807.

PMID:
18344718
14.

Predictable recovery from myasthenia gravis crisis with plasma exchange: thirty-six cases and review of current management.

Mahalati K, Dawson RB, Collins JO, Mayer RF.

J Clin Apher. 1999;14(1):1-8. Review.

PMID:
10355656
15.

[Respective indications of plasma exchange and high-dose immunoglobulins in polyradiculoneuritis and myasthenia gravis].

Raphaël JC, Annane D, Chevret S, Chillet P, Gajdos P.

Presse Med. 1996 Oct 19;25(31):1516-22. Review. French.

PMID:
8958883
16.

Immunoglobulin treatment versus plasma exchange in patients with chronic moderate to severe myasthenia gravis.

Rønager J, Ravnborg M, Hermansen I, Vorstrup S.

Artif Organs. 2001 Dec;25(12):967-73.

PMID:
11843764
17.

Comparison of IVIg and PLEX in patients with myasthenia gravis.

Barth D, Nabavi Nouri M, Ng E, Nwe P, Bril V.

Neurology. 2011 Jun 7;76(23):2017-23. doi: 10.1212/WNL.0b013e31821e5505. Epub 2011 May 11.

18.

Pharmacoeconomics of therapy for Guillain-Barré syndrome: plasma exchange and intravenous immunoglobulin.

Tsai CP, Wang KC, Liu CY, Sheng WY, Lee TC.

J Clin Neurosci. 2007 Jul;14(7):625-9.

PMID:
17532498
19.

Treatment of myasthenia gravis acute exacerbations with intravenous immunoglobulin.

Gajdos P, Chevret S.

Ann N Y Acad Sci. 2008;1132:271-5. Epub 2007 Dec 20.

PMID:
18096850
20.

Intravenous immune globulin in myasthenia gravis.

Gajdos P.

Clin Exp Immunol. 1994 Jul;97 Suppl 1:49-51. Review.

Supplemental Content

Support Center